98 results
Page 2 of 5
8-K
EX-99.2
lbyyvfd ib6nv5bi
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
8-K
EX-1.1
a2w1y3k4zgbz4
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
424B5
hm6930e4m
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
e6in7bnuyrem0j6u 7bk
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
rl6gk
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
gdapnfz
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-10.3
v62osir4n4slo r229
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
5q763do9u m4
28 Aug 20
Prospectus supplement
4:31pm
425
uay2v7zpw2gih9of5
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-2.1
ba8k3 ln6yc
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-99.1
rehr wdzntrna9y0
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-99.2
2yulp9
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm